Sean Conrin, M.D. and Robert Marvin M.D. are Co-Directors of the Metabolic Monitoring Clinic. It is well known that persons with psychiatric disorders have high rates of comorbidity for weight gain, diabetes and high cholesterol associated with the treatment with second-generation antipsychotic agents (SGA). Of major concern, coronary heart disease is among the primary causes of a 20% decreased life-expectancy among patients with schizophrenia compared to the general population. The Psychosis Treatment Program offers on-site medical evaluations and monitoring of weight, blood pressure, blood sugar, and cholesterol. Aneet Ahluwalia M.D., a dual certified Psychiatrist and Internal Medicine specialist is available during the Psychosis Treatment Program Medication Clinic to provide general medical care. Appointments to see Dr. Ahluwalia can be scheduled on the same day as your appointment with your psychiatrist.